People · Operator
Named in public records as an officer, director or promoter · active 2011–2021 · Pharmaceuticals, Biotechnology, Biotech / Pharma, Manufacturing
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Verastem, Inc. | — | Pharmaceuticals | Series C | $163.2M | $3.5B | 2011 |
| Gelesis Inc | — | Biotechnology | Series B | $37.7M | $1.3B | 2015 |
| Pillar Biosciences Inc. | — | Biotech / Pharma | Series B | $20.0M | $511.7M | 2021 |
| MoMelan Technologies, Inc. | — | Manufacturing | Series A | $7.7M | $47.8M | 2011 |
Robert Forrester at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Robert Forrester on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Rishi Gupta | 1 | 12 |
| Elon Boms | 1 | 10 |
| Christoph Westphal | 1 | 8 |
| Timothy Barberich | 1 | 6 |
| John K. Clarke | 1 | 5 |
| Eric Elenko | 1 | 4 |
| Paul Brannelly | 1 | 4 |
| Eric Rowinsky | 1 | 4 |
| Ansbert K Gadicke | 1 | 4 |
| Zhaohui Wang | 1 | 3 |
| Richard Aldrich | 1 | 3 |
| Alison Lawton | 1 | 3 |
| Gang Song | 1 | 3 |
| Yishai Zohar | 1 | 2 |
| Michael Kauffman | 1 | 2 |
| Shawn Liu | 1 | 2 |
| Elliot Maltz | 1 | 2 |
| John LaMattina | 1 | 2 |
| Bruce Wendel | 1 | 2 |
| Meghan Fitzgerald | 1 | 2 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.